ISSN: 1935-1232 (P)
Abstract
New Drug Update
Author(s): Peter F. Buckley, MDNeurocrine Biosciences, Inc. has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for once-daily dosing of valbenazine
Clinical Schizophrenia & Related Psychoses received 6601 citations as per Google Scholar report
Neurocrine Biosciences, Inc. has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for once-daily dosing of valbenazine